Canada approves plant-based Covid-19 vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Subscribe To Our Newsletter & Stay Updated